Merrick I. Ross

1990–2025 年に発表

別表記
Merrick I Ross
212
論文数
51,212
被引用数
116
h 指数
210
i10 指数

被引用数

Merrick I. Ross の年別被引用数1974 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 3 件1995 年: 被引用 7 件1996 年: 被引用 18 件1997 年: 被引用 30 件1998 年: 被引用 53 件1999 年: 被引用 92 件2000 年: 被引用 138 件2001 年: 被引用 158 件2002 年: 被引用 221 件2003 年: 被引用 278 件2004 年: 被引用 273 件2005 年: 被引用 299 件2006 年: 被引用 367 件2007 年: 被引用 299 件2008 年: 被引用 284 件2009 年: 被引用 310 件2010 年: 被引用 342 件2011 年: 被引用 380 件2012 年: 被引用 304 件2013 年: 被引用 302 件2014 年: 被引用 290 件2015 年: 被引用 271 件2016 年: 被引用 265 件2017 年: 被引用 267 件2018 年: 被引用 341 件2019 年: 被引用 1,196 件2020 年: 被引用 1,214 件2021 年: 被引用 1,027 件2022 年: 被引用 904 件2023 年: 被引用 770 件2024 年: 被引用 1,222 件2025 年: 被引用 613 件2026 年: 被引用 18 件1975〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,287 件、この内訳の 30.9%中国: 引用元論文 1,076 件、この内訳の 7.8%ドイツ: 引用元論文 820 件、この内訳の 5.9%イギリス: 引用元論文 805 件、この内訳の 5.8%イタリア: 引用元論文 734 件、この内訳の 5.3%オーストラリア: 引用元論文 701 件、この内訳の 5%オランダ: 引用元論文 655 件、この内訳の 4.7%フランス: 引用元論文 549 件、この内訳の 4%カナダ: 引用元論文 423 件、この内訳の 3%スイス: 引用元論文 338 件、この内訳の 2.4%スペイン: 引用元論文 331 件、この内訳の 2.4%日本: 引用元論文 281 件、この内訳の 2%
0%30.9%その他 20.8%

分野

  • Medicine59.5%
  • Biochemistry, Genetics and Molecular Biology30.3%
  • Immunology and Microbiology6.5%
  • Engineering1.6%
  • Computer Science0.5%
  • Agricultural and Biological Sciences0.2%
  • その他1.4%

トピック

  • Cutaneous Melanoma Detection and Management9.7%
  • Cancer Immunotherapy and Biomarkers7.3%
  • Immunotherapy and Immune Responses6%
  • CAR-T cell therapy research5.4%
  • Breast Cancer Treatment Studies5.2%
  • Melanoma and MAPK Pathways5.2%
  • その他61.2%

共著者

全論文

検索で開く
  1. Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geoffrey T. Gibney, Michael B. Atkins, Montaser Shaheen, James Warneke, Alexandra P. Ikeguchi, Jose Eugenio Najera, Bartosz Chmielowski, Joseph G. Crompton, Justin D. Floyd, Eddy C. Hsueh, Kim Margolin, Warren Chow, Kenneth F. Grossmann, Eliana Dietrich, Víctor G. Prieto, Michael Lowe, Elizabeth I. Buchbinder, John M. Kirkwood, Larissa A. Korde, James Moon, Elad Sharon, Vernon K. Sondak, Antoni Ribas - New England Journal of Medicine 2023 被引用: 827

  2. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mohamed A. Jamal, Erez N. Baruch, Eva Pérez‐Guijarro, Chi‐Ping Day, Glenn Merlino, Barbara Pazdrak, Brooke S. Lochmann, Robert Szczepaniak‐Sloane, Reetakshi Arora, Jaime Anderson, Chrystia M. Zobniw, Eliza Posada, Elizabeth Sirmans, Julie M. Simon, Lauren E. Haydu, Elizabeth M. Burton, Linghua Wang, Minghao Dang, Karen Clise-Dwyer, Sarah Schneider, Thomas Chapman, Nana-Ama A.S. Anang, Sheila Duncan, Joseph Toker, Jared Malke, Isabella C. Glitza, Rodabe N. Amaria, Hussein A. Tawbi, Adi Diab, Michael K. Wong, Sapna P. Patel, Scott E. Woodman, Michael A. Davies, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, V. Behrana Jensen, Yardena Samuels, Ravid Straussman, Nadim J. Ajami, Kelly C. Nelson, Luigi Nezi, Joseph F. Petrosino, P. Andrew Futreal, Alexander J. Lazar, Jianhua Hu, Robert R. Jenq, Michael T. Tetzlaff, Yan Yan, Wendy S. Garrett, Curtis Huttenhower, Padmanee Sharma, Stephanie S. Watowich, James P. Allison, Lorenzo Cohen, Giorgio Trinchieri, Carrie R. Daniel, Jennifer A. Wargo - Science 2021 被引用: 932

  3. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 被引用: 2,598

  4. Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

    著者: , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2017 被引用: 2,286

  5. Neoadjuvant relatlimab and nivolumab in resectable melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sapna P. Patel, Adi Diab, Anthony Lucci, Víctor G. Prieto, Michael A. Davies, James P. Allison, Padmanee Sharma, Jennifer A. Wargo, Charlotte E. Ariyan, Hussein A. Tawbi - Nature 2022 被引用: 332

  6. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liberty Posada, Lauren E. Haydu, Linghua Wang, Shaojun Zhang, Alexander J. Lazar, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Alexandre Reuben, Miles C. Andrews, Christine N. Spencer, Víctor G. Prieto, Padmanee Sharma, James P. Allison, Michael T. Tetzlaff, Jennifer A. Wargo - Nature Medicine 2018 被引用: 826

  7. Final Version of 2009 AJCC Melanoma Staging and Classification

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 4,570

  8. Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 617

  9. Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2018 被引用: 270

  10. Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial

    著者: , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2023 被引用: 89

  11. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evan Wuthrick, Nicole R. McMillian, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2021 被引用: 337

  12. Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , - Nature Medicine 2021 被引用: 148

  13. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guang R. Gao, Hiya Banerjee, Mike Lau, Jeffrey E. Gershenwald, Anthony Lucci, Emily Z. Keung, Merrick I. Ross, Laura Pala, Eleonora Pagan, Rossana Lazcano Segura, Qian Liu, Mikayla Borthwick, Eric Lau, Melinda S. Yates, Shannon N. Westin, Khalida Wani, Michael T. Tetzlaff, Lauren E. Haydu, Mikhila Mahendra, Xiao-Yan Ma, Christopher J. Logothetis, Zachary Kulstad, Sarah B. Johnson, Courtney W. Hudgens, Ningping Feng, Lorenzo Federico, Georgina V. Long, P. Andrew Futreal, Swathi Arur, Hussein A. Tawbi, Amy E. Moran, Linghua Wang, Timothy P. Heffernan, Joseph R. Marszalek, Jennifer A. Wargo - Nature 2022 被引用: 130

  14. Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher Toth, Renjith Ramachandran, Seth Wardell, Audrey M. Gonzalez, Patrick Hwu - Clinical Cancer Research 2012 被引用: 433

  15. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander M.M. Eggermont, Michael A. Davies, Miles C. Andrews, Donald A. Berry, Matthew S. Block, Genevieve M. Boland, Kathryn Bollin, Matteo S. Carlino, Richard D. Carvajal, Jonathan Cohen, Diwakar Davar, Keith A. Delman, Reinhard Dummer, Michael D. Farwell, David E. Fisher, Alberto Fusi, Isabella C. Glitza, Tanja D. de Gruijl, David Gyorki, Axel Hauschild, Tina J. Hieken, James Larkin, David H. Lawson, Célèste Lebbé, Jeffrey E. Lee, Michael Lowe, Jason J. Luke, Grant A. McArthur, David F. McDermott, Jennifer L. McQuade, Tara C. Mitchell, Teresa M. Petrella, Peter A. Prieto, Igor Puzanov, Caroline Robert, April K.S. Salama, Shaneen Sandhu, Dirk Schadendorf, Alexander N. Shoushtari, Jeffrey A. Sosman, Susan M. Swetter, Ken K Tanabe, Samra Turajlic, Douglas S. Tyler, Scott E. Woodman, Frances C. Wright, Jonathan S. Zager, Paolo A. Ascierto, Andrew J. Spillane, Alexander C. J. van Akkooi, Jennifer A. Wargo, Christian U. Blank, Hussein A. Tawbi, Georgina V. Long - The Lancet Oncology 2019 被引用: 218

  16. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth M. Burton, Sangeetha M. Reddy, Padmanee Sharma, James P. Allison, Phillip Andrew Futreal, Scott E. Woodman, Michael A. Davies, Jennifer A. Wargo - The Lancet Oncology 2018 被引用: 290

  17. Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabella C. Glitza, Hussein A. Tawbi, Michael K. Wong, Suzanne Cain, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard E. Royal, Janice N. Cormier, Jennifer A. Wargo, Laszlo Radvanyi, Carlos A. Torres‐Cabala, Rameen Beroukhim, Patrick Hwu, Rodabe N. Amaria, Chantale Bernatchez - Clinical Cancer Research 2018 被引用: 135

  18. Ethnic Differences Among Patients With Cutaneous Melanoma

    著者: , , , , , , , - Archives of Internal Medicine 2006 被引用: 379

  19. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2001 被引用: 2,401

  20. Lymphedema beyond breast cancer

    著者: , , , , , - Cancer 2010 被引用: 512

  21. Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2019 被引用: 438

  22. Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 1999 被引用: 1,337

  23. Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Frontiers in Oncology 2022 被引用: 52

  24. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rohit Sharma, Joseph J. Skitzki, Emily Smith, Katy K. Tsai, Evan Wuthrick, Yan Xing, Nicole R. McMillian, Sara Espinosa - Journal of the National Comprehensive Cancer Network 2024 被引用: 125